Search alternatives:
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
Showing 1,481 - 1,500 results of 101,133 for search '(( 5 wt decrease ) OR ( 5 ((((wt decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.73s Refine Results
  1. 1481
    Chronic exposure of human PAC to nicotine decreases carrier-mediated [<sup>3</sup>H] thiamin uptake.

    Chronic exposure of human PAC to nicotine decreases carrier-mediated [<sup>3</sup>H] thiamin uptake. by Padmanabhan Srinivasan (481324)

    Published 2015
    Save to List
    Saved in:
  2. 1482
    Oleic acid treatment decreases MDA formation, and induces UCP2 and AMPK in septic mice.

    Oleic acid treatment decreases MDA formation, and induces UCP2 and AMPK in septic mice. by Cassiano Felippe Gonçalves-de-Albuquerque (846954)

    Published 2016
    Save to List
    Saved in:
  3. 1483
    Source and purity of the chemicals used in this work.

    Source and purity of the chemicals used in this work. by Hossam K. Abdrabou (16436541)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 1484
    Viscosity of different amine based DESs at room temperature.

    Viscosity of different amine based DESs at room temperature. by Hossam K. Abdrabou (16436541)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 1485
    Parameters of the VFTH equation for temperature dependence of viscosity (mPa.s), together with the correlation coefficients and relative deviation.

    Parameters of the VFTH equation for temperature dependence of viscosity (mPa.s), together with the correlation coefficients and relative deviation. by Hossam K. Abdrabou (16436541)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 1486
    Experimental vs COSMO-RS values for the CO<sub>2</sub> solubility of the studied DESs.

    Experimental vs COSMO-RS values for the CO<sub>2</sub> solubility of the studied DESs. by Hossam K. Abdrabou (16436541)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 1487
    Effect of temperature on CO<sub>2</sub> solubility of amine-based DESs predicted by COSMO-RS.

    Effect of temperature on CO<sub>2</sub> solubility of amine-based DESs predicted by COSMO-RS. by Hossam K. Abdrabou (16436541)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 1488
    Effect of water content on the viscosity and density of the ChCl-MEA (1:6) DESs.

    Effect of water content on the viscosity and density of the ChCl-MEA (1:6) DESs. by Hossam K. Abdrabou (16436541)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 1489
    COSMO-RS prediction for pressure effect on CO<sub>2</sub> solubility of amine-based DESs.

    COSMO-RS prediction for pressure effect on CO<sub>2</sub> solubility of amine-based DESs. by Hossam K. Abdrabou (16436541)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 1490
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1491
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1492
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1493
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1494
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1495
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1496
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1497
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1498
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1499
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1500
    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.

    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: